secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACCENDRA HEALTH INC/VA/ (ACH)
CIK:        0000075252
Form:       8-K
Filed at:   2024-08-02T23:59:59+00:00
Accession:  0001558370-24-010644
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Owens & Minor Q2 revenue up 4% to $2.7B; adjusted EPS doubles to $0.36; agrees to acquire Rotech
--------------------------------------------------------------------------------

- Revenue $2.67B (+4% YoY); GAAP net loss $32M ($0.42 loss per share) vs. $28M loss last year.
- Adjusted EBITDA $127M (+12% YoY); adjusted EPS $0.36 vs. $0.18, doubling year over year.
- Operating cash flow $116M used to reduce debt by $71M during the quarter.
- Agreement to acquire Rotech Healthcare Holdings to expand Patient Direct segment; expected close H2 2024.
- Management reaffirms full-year 2024 adjusted EBITDA guidance of $515M-$545M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/75252/000155837024010644/0001558370-24-010644-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/75252/000155837024010644/tmb-20240802x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-010644

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer